References
Adrover, M. F., Shin, J. H., Quiroz, C., Ferre, S., Lemos, J. C., & Alvarez, V. A. (2020). Prefrontal Cortex-Driven Dopamine Signals in the Striatum Show Unique Spatial and Pharmacological Properties.Journal of Neuroscience, 40 (39), 7510-7522. doi:10.1523/JNEUROSCI.1327-20.2020
An, S., Li, X., Deng, L., Zhao, P., Ding, Z., Han, Y., Luo, Y., Liu, X., Li, A., Luo, Q., Feng, Z., & Gong, H. (2021). A Whole-Brain Connectivity Map of VTA and SNc Glutamatergic and GABAergic Neurons in Mice. Frontiers in Neuroanatomy, 15 , 818242. doi:10.3389/fnana.2021.818242
Anzalone, A., Lizardi-Ortiz, J. E., Ramos, M., De Mei, C., Hopf, F. W., Iaccarino, C., Halbout, B., Jacobsen, J., Kinoshita, C., Welter, M., Caron, M. G., Bonci, A., Sulzer, D., & Borrelli, E. (2012). Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. Journal of Neuroscience,32 (26), 9023-9034. doi:10.1523/JNEUROSCI.0918-12.2012
Aracil-Fernandez, A., Trigo, J. M., Garcia-Gutierrez, M. S., Ortega-Alvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P., Maldonado, R., & Manzanares, J. (2012). Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB(2) receptors. Neuropsychopharmacology, 37 (7), 1749-1763. doi:10.1038/npp.2012.22
Arndt, D. L., Arnold, J. C., & Cain, M. E. (2014). The effects of mGluR2/3 activation on acute and repeated amphetamine-induced locomotor activity in differentially reared male rats. Experimental and Clinical Psychopharmacology, 22 (3), 257-265. doi:10.1037/a0035273
Atigari, D. V., Uprety, R., Pasternak, G. W., Majumdar, S., & Kivell, B. M. (2019). MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.Neuropharmacology, 150 , 217-228. doi:10.1016/j.neuropharm.2019.02.010
Atwood, B. K., Kupferschmidt, D. A., & Lovinger, D. M. (2014). Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum. Nature Neuroscience, 17 (4), 540-548. doi:10.1038/nn.3652
Atwood, B. K., Lovinger, D. M., & Mathur, B. N. (2014). Presynaptic long-term depression mediated by Gi/o-coupled receptors. Trends in Neurosciences, 37 (11), 663-673. doi:10.1016/j.tins.2014.07.010
Augier, E., Dulman, R. S., Rauffenbart, C., Augier, G., Cross, A. J., & Heilig, M. (2016). The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats.Neuropsychopharmacology, 41 (12), 2932-2940. doi:10.1038/npp.2016.107
Bamford, N. S., Wightman, R. M., & Sulzer, D. (2018). Dopamine’s Effects on Corticostriatal Synapses during Reward-Based Behaviors.Neuron, 97 (3), 494-510. doi:10.1016/j.neuron.2018.01.006
Bauzo, R. M., Kimmel, H. L., & Howell, L. L. (2009). Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys. Pharmacology Biochemistry and Behavior, 94 (1), 204-210. doi:10.1016/j.pbb.2009.08.011
Beckstead, M. J., Grandy, D. K., Wickman, K., & Williams, J. T. (2004). Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron, 42 (6), 939-946. doi:10.1016/j.neuron.2004.05.019
Bello, E. P., Mateo, Y., Gelman, D. M., Noain, D., Shin, J. H., Low, M. J., Alvarez, V. A., Lovinger, D. M., & Rubinstein, M. (2011). Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nature Neuroscience, 14 (8), 1033-1038. doi:10.1038/nn.2862
Benoit-Marand, M., Ballion, B., Borrelli, E., Boraud, T., & Gonon, F. (2011). Inhibition of dopamine uptake by D2 antagonists: an in vivo study. Journal of Neurochemistry, 116 (3), 449-458. doi:10.1111/j.1471-4159.2010.07125.x
Berizzi, A. E., Perry, C. J., Shackleford, D. M., Lindsley, C. W., Jones, C. K., Chen, N. A., Sexton, P. M., Christopoulos, A., Langmead, C. J., & Lawrence, A. J. (2018). Muscarinic M(5) receptors modulate ethanol seeking in rats. Neuropsychopharmacology, 43 (7), 1510-1517. doi:10.1038/s41386-017-0007-3
Berke, J. D. (2018). What does dopamine mean? Nature Neuroscience, 21 (6), 787-793. doi:10.1038/s41593-018-0152-y
Buckholtz, J. W., Treadway, M. T., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Shelby, E. S., Smith, C. E., Kessler, R. M., & Zald, D. H. (2010). Dopaminergic network differences in human impulsivity. Science,329 (5991), 532. doi:10.1126/science.1185778
Budygin, E. A., Oleson, E. B., Lee, Y. B., Blume, L. C., Bruno, M. J., Howlett, A. C., Thompson, A. C., & Bass, C. E. (2016). Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity. Frontiers in Behavioral Neuroscience, 10 , 248. doi:10.3389/fnbeh.2016.00248
Byun, N. E., Grannan, M., Bubser, M., Barry, R. L., Thompson, A., Rosanelli, J., Gowrishankar, R., Kelm, N. D., Damon, S., Bridges, T. M., Melancon, B. J., Tarr, J. C., Brogan, J. T., Avison, M. J., Deutch, A. Y., Wess, J., Wood, M. R., Lindsley, C. W., Gore, J. C., Conn, P. J., & Jones, C. K. (2014). Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Neuropsychopharmacology, 39 (7), 1578-1593. doi:10.1038/npp.2014.2
Cachope, R., Mateo, Y., Mathur, B. N., Irving, J., Wang, H. L., Morales, M., Lovinger, D. M., & Cheer, J. F. (2012). Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Reports,2 (1), 33-41. doi:10.1016/j.celrep.2012.05.011
Campos-Jurado, Y., Marti-Prats, L., Zornoza, T., Polache, A., Granero, L., & Cano-Cebrian, M. J. (2017). Regional differences in mu-opioid receptor-dependent modulation of basal dopamine transmission in rat striatum. Neuroscience Letters, 638 , 102-108. doi:10.1016/j.neulet.2016.12.024
Canseco-Alba, A., Schanz, N., Sanabria, B., Zhao, J., Lin, Z., Liu, Q. R., & Onaivi, E. S. (2019). Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons. Behavioural Brain Research,360 , 286-297. doi:10.1016/j.bbr.2018.11.043
Caprioli, D., Justinova, Z., Venniro, M., & Shaham, Y. (2018). Effect of Novel Allosteric Modulators of Metabotropic Glutamate Receptors on Drug Self-administration and Relapse: A Review of Preclinical Studies and Their Clinical Implications. Biological Psychiatry,84 (3), 180-192. doi:10.1016/j.biopsych.2017.08.018
Cardozo, D. L., & Bean, B. P. (1995). Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors. Journal of Neurophysiology, 74 (3), 1137-1148. doi:10.1152/jn.1995.74.3.1137
Charbogne, P., Kieffer, B. L., & Befort, K. (2014). 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology,76 Pt B (0 0), 204-217. doi:10.1016/j.neuropharm.2013.08.028
Cheer, J. F., Wassum, K. M., Sombers, L. A., Heien, M. L., Ariansen, J. L., Aragona, B. J., Phillips, P. E., & Wightman, R. M. (2007). Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. Journal of Neuroscience, 27 (4), 791-795. doi:10.1523/JNEUROSCI.4152-06.2007
Chefer, V. I., Czyzyk, T., Bolan, E. A., Moron, J., Pintar, J. E., & Shippenberg, T. S. (2005). Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.Journal of Neuroscience, 25 (20), 5029-5037. doi:10.1523/JNEUROSCI.0854-05.2005
Collins, A. L., Aitken, T. J., Greenfield, V. Y., Ostlund, S. B., & Wassum, K. M. (2016). Nucleus Accumbens Acetylcholine Receptors Modulate Dopamine and Motivation. Neuropsychopharmacology,41 (12), 2830-2838. doi:10.1038/npp.2016.81
Congar, P., Bergevin, A., & Trudeau, L. E. (2002). D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels. Journal of Neurophysiology,87 (2), 1046-1056. doi:10.1152/jn.00459.2001
Courtney, N. A., Mamaligas, A. A., & Ford, C. P. (2012). Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing. Journal of Neuroscience, 32 (39), 13520-13528. doi:10.1523/JNEUROSCI.2745-12.2012
Cover, K. K., Gyawali, U., Kerkhoff, W. G., Patton, M. H., Mu, C., White, M. G., Marquardt, A. E., Roberts, B. M., Cheer, J. F., & Mathur, B. N. (2019). Activation of the Rostral Intralaminar Thalamus Drives Reinforcement through Striatal Dopamine Release. Cell Reports,26 (6), 1389-1398 e1383. doi:10.1016/j.celrep.2019.01.044
Covey, D. P., Bunner, K. D., Schuweiler, D. R., Cheer, J. F., & Garris, P. A. (2016). Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids. European Journal of Neuroscience,43 (12), 1661-1673. doi:10.1111/ejn.13248
Crawford, J. T., Roberts, D. C., & Beveridge, T. J. (2013). The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats. Drug and Alcohol Dependence, 132 (3), 414-419. doi:10.1016/j.drugalcdep.2013.07.024
Cui, Y., Ostlund, S. B., James, A. S., Park, C. S., Ge, W., Roberts, K. W., Mittal, N., Murphy, N. P., Cepeda, C., Kieffer, B. L., Levine, M. S., Jentsch, J. D., Walwyn, W. M., Sun, Y. E., Evans, C. J., Maidment, N. T., & Yang, X. W. (2014). Targeted expression of mu-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward.Nature Neuroscience, 17 (2), 254-261. doi:10.1038/nn.3622
D’Souza, M. S., Liechti, M. E., Ramirez-Nino, A. M., Kuczenski, R., & Markou, A. (2011). The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats.Neuropsychopharmacology, 36 (10), 2111-2124. doi:10.1038/npp.2011.103
Dall, C., Weikop, P., Dencker, D., Molander, A. C., Wortwein, G., Conn, P. J., Fink-Jensen, A., & Thomsen, M. (2017). Muscarinic receptor M(4) positive allosteric modulators attenuate central effects of cocaine.Drug and Alcohol Dependence, 176 , 154-161. doi:10.1016/j.drugalcdep.2017.03.014
Darcq, E., & Kieffer, B. L. (2018). Opioid receptors: drivers to addiction? Nature Reviews: Neuroscience, 19 (8), 499-514. doi:10.1038/s41583-018-0028-x
de Jong, J. W., Fraser, K. M., & Lammel, S. (2022). Mesoaccumbal Dopamine Heterogeneity: What Do Dopamine Firing and Release Have to Do with It? Annual Review of Neuroscience, 45 , 109-129. doi:10.1146/annurev-neuro-110920-011929
De Klippel, N., Sarre, S., Ebinger, G., & Michotte, Y. (1993). Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats. Brain Research,630 (1-2), 57-64. doi:10.1016/0006-8993(93)90642-z
De Luca, M. A., Bimpisidis, Z., Melis, M., Marti, M., Caboni, P., Valentini, V., Margiani, G., Pintori, N., Polis, I., Marsicano, G., Parsons, L. H., & Di Chiara, G. (2015). Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid. Neuropharmacology, 99 , 705-714. doi:10.1016/j.neuropharm.2015.08.041
Dencker, D., Weikop, P., Sorensen, G., Woldbye, D. P., Wortwein, G., Wess, J., & Fink-Jensen, A. (2012). An allosteric enhancer of M(4) muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine. Psychopharmacology (Berl),224 (2), 277-287. doi:10.1007/s00213-012-2751-8
Di Chiara, G., & Imperato, A. (1988). Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. Journal of Pharmacology and Experimental Therapeutics, 244 (3), 1067-1080. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2855239
Escobar, A. D. P., Casanova, J. P., Andres, M. E., & Fuentealba, J. A. (2020). Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors. Frontiers in Pharmacology, 11 , 57. doi:10.3389/fphar.2020.00057
Fields, H. L., & Margolis, E. B. (2015). Understanding opioid reward.Trends in Neurosciences, 38 (4), 217-225. doi:10.1016/j.tins.2015.01.002
Ford, C. P. (2014). The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience, 282 , 13-22. doi:10.1016/j.neuroscience.2014.01.025
Ford, C. P., Mark, G. P., & Williams, J. T. (2006). Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. Journal of Neuroscience, 26 (10), 2788-2797. doi:10.1523/JNEUROSCI.4331-05.2006
Foster, D. J., Bryant, Z. K., & Conn, P. J. (2021). Targeting muscarinic receptors to treat schizophrenia. Behavioural Brain Research, 405 , 113201. doi:10.1016/j.bbr.2021.113201
Foster, D. J., Gentry, P. R., Lizardi-Ortiz, J. E., Bridges, T. M., Wood, M. R., Niswender, C. M., Sulzer, D., Lindsley, C. W., Xiang, Z., & Conn, P. J. (2014). M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor’s location. Journal of Neuroscience, 34 (9), 3253-3262. doi:10.1523/JNEUROSCI.4896-13.2014
Foster, D. J., Wilson, J. M., Remke, D. H., Mahmood, M. S., Uddin, M. J., Wess, J., Patel, S., Marnett, L. J., Niswender, C. M., Jones, C. K., Xiang, Z., Lindsley, C. W., Rook, J. M., & Conn, P. J. (2016). Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.Neuron, 91 (6), 1244-1252. doi:10.1016/j.neuron.2016.08.017
French, E. D., Dillon, K., & Wu, X. (1997). Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.Neuroreport, 8 (3), 649-652. doi:10.1097/00001756-199702100-00014
Garrison, A. T., Orsi, D. L., Capstick, R. A., Whomble, D., Li, J., Carter, T. R., Felts, A. S., Vinson, P. N., Rodriguez, A. L., Han, A., Hajari, K., Cho, H. P., Teal, L. B., Ragland, M. G., Ghamari-Langroudi, M., Bubser, M., Chang, S., Schnetz-Boutaud, N. C., Boutaud, O., Blobaum, A. L., Foster, D. J., Niswender, C. M., Conn, P. J., Lindsley, C. W., Jones, C. K., & Han, C. (2022). Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M(5) Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder. Journal of Medicinal Chemistry, 65 (8), 6273-6286. doi:10.1021/acs.jmedchem.2c00192
Gessa, G. L., Melis, M., Muntoni, A. L., & Diana, M. (1998). Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. European Journal of Pharmacology,341 (1), 39-44. doi:10.1016/s0014-2999(97)01442-8
Gould, R. W., Gunter, B. W., Bubser, M., Matthews, R. T., Teal, L. B., Ragland, M. G., Bridges, T. M., Garrison, A. T., Winder, D. G., Lindsley, C. W., & Jones, C. K. (2019). Acute Negative Allosteric Modulation of M(5) Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on Antinociception. ACS Chemical Neuroscience, 10 (8), 3740-3750. doi:10.1021/acschemneuro.9b00274
Gray, A. M., Rawls, S. M., Shippenberg, T. S., & McGinty, J. F. (1999). The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. Journal of Neurochemistry,73 (3), 1066-1074. doi:10.1046/j.1471-4159.1999.0731066.x
Graziane, N. M., Polter, A. M., Briand, L. A., Pierce, R. C., & Kauer, J. A. (2013). Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron, 77 (5), 942-954. doi:10.1016/j.neuron.2012.12.034
Gunter, B. W., Gould, R. W., Bubser, M., McGowan, K. M., Lindsley, C. W., & Jones, C. K. (2018). Selective inhibition of M(5) muscarinic acetylcholine receptors attenuates cocaine self-administration in rats.Addiction Biology, 23 (5), 1106-1116. doi:10.1111/adb.12567
Han, X., Liang, Y., Hempel, B., Jordan, C. J., Shen, H., Bi, G. H., Li, J., & Xi, Z. X. (2023). Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice. Journal of Neuroscience, 43 (3), 373-385. doi:10.1523/JNEUROSCI.1493-22.2022
Hillemacher, T., Heberlein, A., Muschler, M. A., Bleich, S., & Frieling, H. (2011). Opioid modulators for alcohol dependence.Expert Opinion on Investigational Drugs, 20 (8), 1073-1086. doi:10.1517/13543784.2011.592139
Holroyd, K. B., Adrover, M. F., Fuino, R. L., Bock, R., Kaplan, A. R., Gremel, C. M., Rubinstein, M., & Alvarez, V. A. (2015). Loss of feedback inhibition via D2 autoreceptors enhances acquisition of cocaine taking and reactivity to drug-paired cues.Neuropsychopharmacology, 40 (6), 1495-1509. doi:10.1038/npp.2014.336
Jin, X., Semenova, S., Yang, L., Ardecky, R., Sheffler, D. J., Dahl, R., Conn, P. J., Cosford, N. D., & Markou, A. (2010). The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats. Neuropsychopharmacology,35 (10), 2021-2036. doi:10.1038/npp.2010.82
Johnson, K. A. (2021). Classic and modern approaches to investigating interactions between dopamine systems and metabotropic glutamate receptors. In M. F. B. Olive, B.T.; Leyrer-Jackson, J.M. (Ed.),Metabotropic Glutamate Receptor Technologies , (pp. 135-172). New York, N.Y.: Humana Press.
Johnson, K. A., & Lovinger, D. M. (2016). Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? Frontiers in Cellular Neuroscience, 10 , 264. doi:10.3389/fncel.2016.00264
Johnson, K. A., & Lovinger, D. M. (2020). Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations. Advances in Pharmacology,88 , 193-232. doi:10.1016/bs.apha.2020.02.002
Johnson, K. A., Mateo, Y., & Lovinger, D. M. (2017). Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum. Neuropharmacology, 117 , 114-123. doi:10.1016/j.neuropharm.2017.01.038
Johnson, K. A., Voyvodic, L., Loewinger, G. C., Mateo, Y., & Lovinger, D. M. (2020). Operant self-stimulation of thalamic terminals in the dorsomedial striatum is constrained by metabotropic glutamate receptor 2. Neuropsychopharmacology, 45 (9), 1454-1462. doi:10.1038/s41386-020-0626-y
Johnson, S. W., & North, R. A. (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. Journal of Neuroscience, 12 (2), 483-488. doi:10.1523/JNEUROSCI.12-02-00483.1992
Jordan, C. J., & Xi, Z. X. (2021). Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals. Frontiers in Neuroscience, 15 , 811192. doi:10.3389/fnins.2021.811192
Joseph, L., & Thomsen, M. (2017). Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M(1), M(2), and M(4) receptor knockout mice.Behavioural Brain Research, 329 , 75-83. doi:10.1016/j.bbr.2017.04.023
Justinova, Z., Panlilio, L. V., Secci, M. E., Redhi, G. H., Schindler, C. W., Cross, A. J., Mrzljak, L., Medd, A., Shaham, Y., & Goldberg, S. R. (2015). The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys. Biological Psychiatry,78 (7), 452-462. doi:10.1016/j.biopsych.2015.01.014
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009). Endocannabinoid-mediated control of synaptic transmission. Physiological Reviews, 89 (1), 309-380. doi:10.1152/physrev.00019.2008
Karkhanis, A., Holleran, K. M., & Jones, S. R. (2017). Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction. International Review of Neurobiology,136 , 53-88. doi:10.1016/bs.irn.2017.08.001
Karkhanis, A. N., Huggins, K. N., Rose, J. H., & Jones, S. R. (2016). Switch from excitatory to inhibitory actions of ethanol on dopamine levels after chronic exposure: Role of kappa opioid receptors.Neuropharmacology, 110 (Pt A), 190-197. doi:10.1016/j.neuropharm.2016.07.022
Katsidoni, V., Kastellakis, A., & Panagis, G. (2013). Biphasic effects of Delta9-tetrahydrocannabinol on brain stimulation reward and motor activity. International Journal of Neuropsychopharmacology,16 (10), 2273-2284. doi:10.1017/S1461145713000709
Kivell, B., Uzelac, Z., Sundaramurthy, S., Rajamanickam, J., Ewald, A., Chefer, V., Jaligam, V., Bolan, E., Simonson, B., Annamalai, B., Mannangatti, P., Prisinzano, T. E., Gomes, I., Devi, L. A., Jayanthi, L. D., Sitte, H. H., Ramamoorthy, S., & Shippenberg, T. S. (2014). Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology,86 , 228-240. doi:10.1016/j.neuropharm.2014.07.016
Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry, 3 (8), 760-773. doi:10.1016/S2215-0366(16)00104-8
Kosillo, P., Zhang, Y. F., Threlfell, S., & Cragg, S. J. (2016). Cortical Control of Striatal Dopamine Transmission via Striatal Cholinergic Interneurons. Cerebral Cortex, 26 (11), 4160-4169. doi:10.1093/cercor/bhw252
Kramer, P. F., Brill-Weil, S. G., Cummins, A. C., Zhang, R., Camacho-Hernandez, G. A., Newman, A. H., Eldridge, M. A. G., Averbeck, B. B., & Khaliq, Z. M. (2022). Synaptic-like axo-axonal transmission from striatal cholinergic interneurons onto dopaminergic fibers.Neuron, 110 (18), 2949-2960 e2944. doi:10.1016/j.neuron.2022.07.011
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014). Muscarinic acetylcholine receptors: novel opportunities for drug development. Nature Reviews: Drug Discovery, 13 (7), 549-560. doi:10.1038/nrd4295
Kupferschmidt, D. A., & Lovinger, D. M. (2015). Inhibition of presynaptic calcium transients in cortical inputs to the dorsolateral striatum by metabotropic GABA(B) and mGlu2/3 receptors. Journal of Physiology, 593 (10), 2295-2310. doi:10.1113/JP270045
Kutlu, M. G., Zachry, J. E., Melugin, P. R., Cajigas, S. A., Chevee, M. F., Kelly, S. J., Kutlu, B., Tian, L., Siciliano, C. A., & Calipari, E. S. (2021). Dopamine release in the nucleus accumbens core signals perceived saliency. Current Biology, 31 (21), 4748-4761 e4748. doi:10.1016/j.cub.2021.08.052
Labouesse, M. A., & Patriarchi, T. (2021). A versatile GPCR toolkit to track in vivo neuromodulation: not a one-size-fits-all sensor.Neuropsychopharmacology, 46 (12), 2043-2047. doi:10.1038/s41386-021-00982-y
Lacey, M. G., Mercuri, N. B., & North, R. A. (1987). Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. Journal of Physiology,392 , 397-416. doi:10.1113/jphysiol.1987.sp016787
Lee, F. J., Pei, L., Moszczynska, A., Vukusic, B., Fletcher, P. J., & Liu, F. (2007). Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.EMBO Journal, 26 (8), 2127-2136. doi:10.1038/sj.emboj.7601656
Li, X., D’Souza, M. S., Nino, A. M., Doherty, J., Cross, A., & Markou, A. (2016). Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats. Psychopharmacology (Berl), 233 (10), 1801-1814. doi:10.1007/s00213-016-4220-2
Liechti, M. E., Lhuillier, L., Kaupmann, K., & Markou, A. (2007). Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. Journal of Neuroscience, 27 (34), 9077-9085. doi:10.1523/JNEUROSCI.1766-07.2007
Liu, C., Cai, X., Ritzau-Jost, A., Kramer, P. F., Li, Y., Khaliq, Z. M., Hallermann, S., & Kaeser, P. S. (2022). An action potential initiation mechanism in distal axons for the control of dopamine release.Science, 375 (6587), 1378-1385. doi:10.1126/science.abn0532
Lovinger, D. M., Mateo, Y., Johnson, K. A., Engi, S. A., Antonazzo, M., & Cheer, J. F. (2022). Local modulation by presynaptic receptors controls neuronal communication and behaviour. Nature Reviews: Neuroscience, 23 (4), 191-203. doi:10.1038/s41583-022-00561-0
Luscher, C., Robbins, T. W., & Everitt, B. J. (2020). The transition to compulsion in addiction. Nature Reviews Neuroscience,21 (5), 247-263. doi:10.1038/s41583-020-0289-z
Ma, Z., Gao, F., Larsen, B., Gao, M., Luo, Z., Chen, D., Ma, X., Qiu, S., Zhou, Y., Xie, J., Xi, Z. X., & Wu, J. (2019). Mechanisms of cannabinoid CB(2) receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area. EBioMedicine,42 , 225-237. doi:10.1016/j.ebiom.2019.03.040
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2003). Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.Journal of Neuroscience, 23 (31), 9981-9986. doi:10.1523/JNEUROSCI.23-31-09981.2003
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2005). Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. Journal of Neurophysiology,93 (6), 3086-3093. doi:10.1152/jn.00855.2004
Margolis, E. B., & Karkhanis, A. N. (2019). Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.Neurochemistry International, 129 , 104504. doi:10.1016/j.neuint.2019.104504
Martel, J. C., & Gatti McArthur, S. (2020). Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia.Frontiers in Pharmacology, 11 , 1003. doi:10.3389/fphar.2020.01003
Martel, P., Leo, D., Fulton, S., Berard, M., & Trudeau, L. E. (2011). Role of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor function. PLoS One, 6 (5), e20402. doi:10.1371/journal.pone.0020402
Mateo, Y., Johnson, K. A., Covey, D. P., Atwood, B. K., Wang, H. L., Zhang, S., Gildish, I., Cachope, R., Bellocchio, L., Guzman, M., Morales, M., Cheer, J. F., & Lovinger, D. M. (2017). Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens. Neuron, 96 (5), 1112-1126 e1115. doi:10.1016/j.neuron.2017.11.012
Matthes, H. W., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dolle, P., Tzavara, E., Hanoune, J., Roques, B. P., & Kieffer, B. L. (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature,383 (6603), 819-823. doi:10.1038/383819a0
Mayfield, R. D., & Zahniser, N. R. (2001). Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Molecular Pharmacology,59 (1), 113-121. doi:10.1124/mol.59.1.113
Mohebi, A., Pettibone, J. R., Hamid, A. A., Wong, J. T., Vinson, L. T., Patriarchi, T., Tian, L., Kennedy, R. T., & Berke, J. D. (2019). Dissociable dopamine dynamics for learning and motivation.Nature, 570 (7759), 65-70. doi:10.1038/s41586-019-1235-y
Mohebi, A. C., V.L.; Berke, J.D. (2022). Cholinergic interneurons drive motivation by promoting dopamine release in the nucleus accumbensbioRxiv doi:https://doi.org/10.1101/2022.11.06.515335
Negus, S. S., Mello, N. K., Portoghese, P. S., & Lin, C. E. (1997). Effects of kappa opioids on cocaine self-administration by rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics,282 (1), 44-55. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9223538
Niswender, C. M., & Conn, P. J. (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annual Review of Pharmacology and Toxicology, 50 , 295-322. doi:10.1146/annurev.pharmtox.011008.145533
Nolan, S. O., Zachry, J. E., Johnson, A. R., Brady, L. J., Siciliano, C. A., & Calipari, E. S. (2020). Direct dopamine terminal regulation by local striatal microcircuitry. Journal of Neurochemistry,155 (5), 475-493. doi:10.1111/jnc.15034
Oleson, E. B., Beckert, M. V., Morra, J. T., Lansink, C. S., Cachope, R., Abdullah, R. A., Loriaux, A. L., Schetters, D., Pattij, T., Roitman, M. F., Lichtman, A. H., & Cheer, J. F. (2012). Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron, 73 (2), 360-373. doi:10.1016/j.neuron.2011.11.018
Pehrson, A. L., & Moghaddam, B. (2010). Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion. Psychopharmacology (Berl), 211 (4), 443-455. doi:10.1007/s00213-010-1914-8
Pentney, R. J., & Gratton, A. (1991). Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study.Neuroscience, 45 (1), 95-102. doi:10.1016/0306-4522(91)90106-x
Perra, S., Clements, M. A., Bernier, B. E., & Morikawa, H. (2011). In vivo ethanol experience increases D(2) autoinhibition in the ventral tegmental area. Neuropsychopharmacology, 36 (5), 993-1002. doi:10.1038/npp.2010.237
Peters, K. Z., Cheer, J. F., & Tonini, R. (2021). Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System.Trends in Neurosciences, 44 (6), 464-477. doi:10.1016/j.tins.2021.02.001
Peters, K. Z., Oleson, E. B., & Cheer, J. F. (2021). A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction. Cold Spring Harbor Perspectives in Medicine,11 (1)doi:10.1101/cshperspect.a039305
Polter, A. M., Bishop, R. A., Briand, L. A., Graziane, N. M., Pierce, R. C., & Kauer, J. A. (2014). Poststress block of kappa opioid receptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking. Biological Psychiatry,76 (10), 785-793. doi:10.1016/j.biopsych.2014.04.019
Ponterio, G., Tassone, A., Sciamanna, G., Riahi, E., Vanni, V., Bonsi, P., & Pisani, A. (2013). Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum. Neuropharmacology, 75 , 78-85. doi:10.1016/j.neuropharm.2013.07.006
Reeves, K. C., Shah, N., Munoz, B., & Atwood, B. K. (2022). Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.Frontiers in Molecular Neuroscience, 15 , 919773. doi:10.3389/fnmol.2022.919773
Rifkin, R. A., Moss, S. J., & Slesinger, P. A. (2017). G Protein-Gated Potassium Channels: A Link to Drug Addiction. Trends in Pharmacological Sciences, 38 (4), 378-392. doi:10.1016/j.tips.2017.01.007
Sgroi, S., & Tonini, R. (2018). Opioidergic Modulation of Striatal Circuits, Implications in Parkinson’s Disease and Levodopa Induced Dyskinesia. Frontiers in Neurology, 9 , 524. doi:10.3389/fneur.2018.00524
Shansky, R. M., & Murphy, A. Z. (2021). Considering sex as a biological variable will require a global shift in science culture. Nature Neuroscience, 24 (4), 457-464. doi:10.1038/s41593-021-00806-8
Shin, J. H., Adrover, M. F., Wess, J., & Alvarez, V. A. (2015). Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America, 112 (26), 8124-8129. doi:10.1073/pnas.1508846112
Smolders, I., Bogaert, L., Ebinger, G., & Michotte, Y. (1997). Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis. Journal of Neurochemistry, 68 (5), 1942-1948. doi:10.1046/j.1471-4159.1997.68051942.x
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America, 89 (6), 2046-2050. doi:10.1073/pnas.89.6.2046
Spodnick, M. B., Amirault, R. T., Towner, T. T., Varlinskaya, E. I., Spear, L. P., & Karkhanis, A. N. (2020). Adolescent Intermittent Ethanol Exposure Effects on Kappa Opioid Receptor Mediated Dopamine Transmission: Sex and Age of Exposure Matter. Brain Science,10 (8)doi:10.3390/brainsci10080472
Stamford, J. A., Kruk, Z. L., & Millar, J. (1991). Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data. British Journal of Pharmacology, 102 (1), 45-50. doi:10.1111/j.1476-5381.1991.tb12130.x
Stein, C. (2016). Opioid Receptors. Annual Review of Medicine,67 , 433-451. doi:10.1146/annurev-med-062613-093100
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016). Striatal dopamine neurotransmission: regulation of release and uptake. Basal Ganglia, 6 (3), 123-148. doi:10.1016/j.baga.2016.02.001
Teal, L. B., Gould, R. W., Felts, A. S., & Jones, C. K. (2019). Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders.Advances in Pharmacology, 86 , 153-196. doi:10.1016/bs.apha.2019.05.001
Threlfell, S., Clements, M. A., Khodai, T., Pienaar, I. S., Exley, R., Wess, J., & Cragg, S. J. (2010). Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.Journal of Neuroscience, 30 (9), 3398-3408. doi:10.1523/JNEUROSCI.5620-09.2010
Threlfell, S., Lalic, T., Platt, N. J., Jennings, K. A., Deisseroth, K., & Cragg, S. J. (2012). Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron,75 (1), 58-64. doi:10.1016/j.neuron.2012.04.038
Tung, L. W., Lu, G. L., Lee, Y. H., Yu, L., Lee, H. J., Leishman, E., Bradshaw, H., Hwang, L. L., Hung, M. S., Mackie, K., Zimmer, A., & Chiou, L. C. (2016). Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons. Nature Communications, 7 , 12199. doi:10.1038/ncomms12199
Tzavara, E. T., Bymaster, F. P., Davis, R. J., Wade, M. R., Perry, K. W., Wess, J., McKinzie, D. L., Felder, C., & Nomikos, G. G. (2004). M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies. FASEB Journal,18 (12), 1410-1412. doi:10.1096/fj.04-1575fje
Underhill, S. M., & Amara, S. G. (2021). Acetylcholine Receptor Stimulation Activates Protein Kinase C Mediated Internalization of the Dopamine Transporter. Frontiers in Cellular Neuroscience,15 , 662216. doi:10.3389/fncel.2021.662216
Urban, N. B., & Martinez, D. (2012). Neurobiology of addiction: insight from neurochemical imaging. Psychiatric Clinics of North America,35 (2), 521-541. doi:10.1016/j.psc.2012.03.011
Vilaro, M. T., Palacios, J. M., & Mengod, G. (1990). Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neuroscience Letters, 114 (2), 154-159. doi:10.1016/0304-3940(90)90064-g
Volkow, N. D., & Morales, M. (2015). The Brain on Drugs: From Reward to Addiction. Cell, 162 (4), 712-725. doi:10.1016/j.cell.2015.07.046
Walker, L. C., Berizzi, A. E., Chen, N. A., Rueda, P., Perreau, V. M., Huckstep, K., Srisontiyakul, J., Govitrapong, P., Xiaojian, J., Lindsley, C. W., Jones, C. K., Riddy, D. M., Christopoulos, A., Langmead, C. J., & Lawrence, A. J. (2020). Acetylcholine Muscarinic M(4) Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents. Biological Psychiatry, 88 (12), 898-909. doi:10.1016/j.biopsych.2020.02.019
Walker, L. C., & Lawrence, A. J. (2020). Allosteric modulation of muscarinic receptors in alcohol and substance use disorders.Advances in Pharmacology, 88 , 233-275. doi:10.1016/bs.apha.2020.01.003
Walton, M. E., & Bouret, S. (2019). What Is the Relationship between Dopamine and Effort? Trends in Neurosciences, 42 (2), 79-91. doi:10.1016/j.tins.2018.10.001
Wang, H., & Lupica, C. R. (2014). Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. Progress in Neuropsychopharmacology and Biological Psychiatry, 52 , 24-27. doi:10.1016/j.pnpbp.2014.01.019
Wang, H., Treadway, T., Covey, D. P., Cheer, J. F., & Lupica, C. R. (2015). Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area. Cell Reports, 12 (12), 1997-2008. doi:10.1016/j.celrep.2015.08.041
Weikop, P., Jensen, K. L., & Thomsen, M. (2020). Effects of muscarinic M(1) receptor stimulation on reinforcing and neurochemical effects of cocaine in rats. Neuropsychopharmacology, 45 (12), 1994-2002. doi:10.1038/s41386-020-0684-1
Weiner, D. M., Levey, A. I., & Brann, M. R. (1990). Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proceedings of the National Academy of Sciences of the United States of America, 87 (18), 7050-7054. doi:10.1073/pnas.87.18.7050
Wise, R. A., & Robble, M. A. (2020). Dopamine and Addiction. Annu Rev Psychol, 71 , 79-106. doi:10.1146/annurev-psych-010418-103337
Wolf, M. E., & Roth, R. H. (1990). Autoreceptor regulation of dopamine synthesis. Annals of the New York Academy of Sciences,604 , 323-343. doi:10.1111/j.1749-6632.1990.tb32003.x
Wolf, M. E., White, F. J., Nassar, R., Brooderson, R. J., & Khansa, M. R. (1993). Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization.Journal of Pharmacology and Experimental Therapeutics,264 (1), 249-255. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8093727
Yamada, K., Takahashi, S., Karube, F., Fujiyama, F., Kobayashi, K., Nishi, A., & Momiyama, T. (2016). Neuronal circuits and physiological roles of the basal ganglia in terms of transmitters, receptors and related disorders. Journal of Physiological Sciences,66 (6), 435-446. doi:10.1007/s12576-016-0445-4
Yanovsky, Y., Mades, S., & Misgeld, U. (2003). Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.Neuroscience, 122 (2), 317-328. doi:10.1016/s0306-4522(03)00607-9
Yorgason, J. T., Zeppenfeld, D. M., & Williams, J. T. (2017). Cholinergic Interneurons Underlie Spontaneous Dopamine Release in Nucleus Accumbens. Journal of Neuroscience, 37 (8), 2086-2096. doi:10.1523/JNEUROSCI.3064-16.2017
Zachry, J. E., Nolan, S. O., Brady, L. J., Kelly, S. J., Siciliano, C. A., & Calipari, E. S. (2021). Sex differences in dopamine release regulation in the striatum. Neuropsychopharmacology,46 (3), 491-499. doi:10.1038/s41386-020-00915-1
Zhang, H. Y., Gao, M., Liu, Q. R., Bi, G. H., Li, X., Yang, H. J., Gardner, E. L., Wu, J., & Xi, Z. X. (2014). Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proceedings of the National Academy of Sciences of the United States of America, 111 (46), E5007-5015. doi:10.1073/pnas.1413210111
Zhang, W., Yamada, M., Gomeza, J., Basile, A. S., & Wess, J. (2002). Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. Journal of Neuroscience, 22 (15), 6347-6352. doi:10.1523/JNEUROSCI.22-15-06347.2002
Zhang, Y. F., & Cragg, S. J. (2017). Pauses in Striatal Cholinergic Interneurons: What is Revealed by Their Common Themes and Variations?Frontiers in Systems Neuroscience, 11 , 80. doi:10.3389/fnsys.2017.00080